Cabaletta Bio CABA
NASDAQ CABA
$1.90 -0.01 (-0.78%)
As of: Oct 1, 2026 · 10:07 AM EDT

Cabaletta Bio (CABA) Liabilities and Shareholders Equity (2018 - 2026)

Updated

Cabaletta Bio (CABA) posted Liabilities and Shareholders Equity of $256.73 million for Q2 2026, up 14.4% from $224.5 million a year earlier.

Analysis

Cabaletta Bio (CABA) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends

At the end of FY2025, Cabaletta Bio's Liabilities and Shareholders Equity came in at $165.08 million, down 10.8% from FY2024.

  • Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 7.5% (FY2020 to FY2025).
  • In prior years, Cabaletta Bio's Liabilities and Shareholders Equity was $185.05 million in FY2024 (-27.0%), $253.65 million in FY2023 (+116.9%), $116.97 million in FY2022 (-7.4%) and $126.34 million in FY2021 (+10.1%).
  • The Q2 2026 figure stands as the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2018.
  • On a year-over-year basis, Liabilities and Shareholders Equity increased in three of the last seven quarters, with an average decline of 5.8%.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q1 2024, with growth of 132.4%; the weakest was Q1 2025, with a decline of 31.3%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Cabaletta Bio 325.53 Mn 325.53 Mn - 256.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 256.73 Mn
Dec 31, 2025 165.08 Mn
Sep 30, 2025 189.76 Mn
Jun 30, 2025 224.50 Mn
Mar 31, 2025 165.14 Mn
Dec 31, 2024 185.05 Mn
Sep 30, 2024 204.41 Mn
Jun 30, 2024 217.42 Mn
Mar 31, 2024 240.46 Mn
Dec 31, 2023 253.65 Mn
Sep 30, 2023 173.29 Mn
Jun 30, 2023 184.64 Mn
Mar 31, 2023 103.45 Mn
Dec 31, 2022 116.97 Mn
Sep 30, 2022 91.68 Mn
Jun 30, 2022 102.02 Mn
Mar 31, 2022 113.66 Mn
Dec 31, 2021 126.34 Mn
Sep 30, 2021 122.64 Mn
Jun 30, 2021 106.93 Mn
API Access

Cabaletta Bio Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CABA&period=max&api_key=YOUR_API_KEY